phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Allodynia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Fang, Q; Li, N; Niu, J; Xiao, J; Xu, B; Xu, K; Zhang, M; Zhang, Q; Zhang, R; Zhao, G; Zhu, H | 1 |
| Decker, AM; Harris, DL; Langston, TL; Li, JX; Mathews, KM; Nguyen, T; Runyon, SP; Siemian, JN; Zhang, Y | 1 |
| Ancel, C; Beltramo, M; Ben Boujema, M; Bertin, I; Bihel, F; Bourguignon, JJ; Bucher, B; Elhabazi, K; Humbert, JP; Ilien, B; Laboureyras, E; Meziane, H; Petit-Demoulière, B; Quillet, R; Schmitt, M; Schneider, E; Schneider, S; Simonin, F; Simonneaux, V; Simonnet, G; Sorg, T; Utard, V | 1 |
| Bajpai, A; Bertozzi, F; Gardell, LR; Gaubert, G; Jacobi, PM; Kelly, N; Lameh, J; Nguyen, D; Olsson, R | 1 |
| Iadarola, MJ; Yang, HY | 1 |
| Panula, P; Pertovaara, A; Wei, H | 2 |
| Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Privat, AM; Zajac, JM | 1 |
| Kalmari, J; Keski-Vakkuri, U; Panula, P; Pertovaara, A; Wei, H | 1 |
| Bihel, F; Drieu la Rochelle, A; Elhabazi, K; Gizzi, P; Henningsen, JB; Ilien, B; Kugler, V; Quillet, R; Schmitt, M; Schneider, S; Simonin, F; Simonneaux, V; Utard, V | 1 |
10 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Allodynia
| Article | Year |
|---|---|
Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
Topics: Acetic Acid; Analgesics, Opioid; Animals; Drug Tolerance; Fascia; Formaldehyde; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Mice; Morphine; Oligopeptides; Pain; Rats, Wistar | 2020 |
Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists.
Topics: Analgesics, Opioid; Animals; Blood-Brain Barrier; Fentanyl; Hyperalgesia; Narcotic Antagonists; Oligopeptides; Proline; Rats; Receptors, Neuropeptide; Structure-Activity Relationship | 2017 |
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
Topics: Administration, Oral; Analgesics, Opioid; Animals; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Fentanyl; Humans; Hyperalgesia; Male; Mesocricetus; Mice; Mice, Inbred C57BL; Narcotic Antagonists; Oligopeptides; Peptides; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Valine | 2017 |
Neuropeptide FF receptors have opposing modulatory effects on nociception.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Disease Models, Animal; Hyperalgesia; Ligands; Male; Mice; Mononeuropathies; NIH 3T3 Cells; Oligopeptides; Pain Measurement; Pain Threshold; Rats; Receptors, Neuropeptide; Small Molecule Libraries; Transfection | 2010 |
Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats.
Topics: Animals; Carrageenan; Gene Expression Regulation; Hindlimb; Hyperalgesia; Inflammation; Inflammation Mediators; Male; Nociceptors; Oligopeptides; Pain Measurement; Peptide Fragments; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Neuropeptide; RNA, Messenger | 2003 |
A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone.
Topics: Animals; Drug Interactions; Hindlimb; Hyperalgesia; Male; Microinjections; Morphine; Naloxone; Narcotic Antagonists; Neuralgia; Oligopeptides; Pain; Periaqueductal Gray; Rats; Rats, Wistar; Skin; Spinal Nerves; Touch | 1998 |
Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Oligopeptides; Pain; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors; Vocalization, Animal | 1999 |
Modulation of pain by [1DMe]NPYF, a stable analogue of neuropeptide FF, in neuropathic rats.
Topics: Animals; Behavior, Animal; Chronic Disease; Electric Stimulation; H-Reflex; Hot Temperature; Hyperalgesia; Injections, Spinal; Nervous System Diseases; Neurons; Nociceptors; Oligopeptides; Pain; Periaqueductal Gray; Rats; Reference Values; Spinal Cord; Touch | 2001 |
Response properties of neurons in the rostroventromedial medulla of neuropathic rats: attempted modulation of responses by [1DMe]NPYF, a neuropeptide FF analogue.
Topics: Action Potentials; Adjuvants, Anesthesia; Animals; Contrast Media; Hyperalgesia; Ligation; Male; Medulla Oblongata; Methysergide; Neural Pathways; Neuralgia; Oligopeptides; Pain Measurement; Pentobarbital; Periaqueductal Gray; Peripheral Nervous System Diseases; Physical Stimulation; Raphe Nuclei; Rats; Rats, Wistar; Reaction Time; Reticular Formation; Serotonin; Serotonin Antagonists; Spinal Nerves | 2001 |
Identification of an
Topics: Analgesics, Opioid; Animals; Cricetinae; Dipeptides; Female; Fentanyl; Half-Life; Humans; Hyperalgesia; Luteinizing Hormone; Male; Mice; Mice, Inbred C57BL; Neuropeptides; Protein Isoforms; Receptors, Neuropeptide; Receptors, Opioid; Structure-Activity Relationship | 2021 |